ReviewUrologie (Heidelberg, Germany)2026

[Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer].

Carsten Ohlmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.